Headache & Pain

Filter Your Results

 

News

 

Cannabinoids and the Endocannabinoid System: Emerging Trends

Shawn Masia, MD and Ryan Zaklin, MD, MA

November/December 2016—Cannabis-derived therapies may offer a great opportunity to modulate the endocannabinoid system, but understanding the risks is paramount.

The Role of Abuse Deterrent Formulations of Opioids in Pain Management

Gerard DeGregoris III, MD, Steve Arrieta, BA, Steven Mandel, MD, and Steve Aydin, DO

November/December 2016—An emerging class of potentially safer opioid medications will offer new challenges and opportunities for both patients and physicians.

Investigational Biologic for the Treatment of Migraine Shows Promise in Phase 3 Data

Thursday, November 17, 2016—New Phase 3 trial results suggest that Amgen’s investigational biologic agent erenumab may be effective at reducing migraines. Erenumab was specifically designed to…

New MRI Labeling Approved for St. Jude Medical’s SCS System

Tuesday, November 15, 2016—The FDA has approved new labeling for full-body magnetic resonance imaging (MRI) for St. Jude Medical’s Proclaim Elite Spinal Cord Stimulation (SCS) System. The new labe…

Oral Bacteria Linked to Migraine

Monday, October 24, 2016—Oral bacteria that convert nitrates into nitric oxide in the blood may be the key to understanding the cause of migraines, according to newly published findings. In a study pu…

Peripheral Neuropathy: Keys to Diagnosis, Management, and Patient Communication

Janice Wiesman, MD

October 2016—Empowering patients to make lifestyle changes plays an essential role in managing peripheral neuropathy.

Idiopathic Intracranial Hypertension: Papilledema and Neuro-Ophthalmology Referral Patterns

Paul G. Mathew, MD, Umer Najib, MD, Regina Krel, MD, and Paul B. Rizzoli, MD

October 2016—Given the relatively small number of neuro-ophthalmology specialists in the US, it is incumbent upon neurologists to diagnose and manage IIH.

FDA Greenlights Spinal Cord Stimulation Therapy for Patients with Chronic Pain

Wednesday, October 05, 2016—The FDA has approved BurstDR stimulation, a physician-designed form of spinal cord stimulation (SCS) for patients with chronic pain. According to manufacturer St. Jude Me…

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.

 
  • BRYN MAWR COMMUNICATIONS III, LLC